fda ends tirzepatide shortage removed from list Announced Removal of Tirzepatide the Drug Shortage List Compounders protest as FDA removes – May 18, 2026: FDA warns

Revisiting the 1957 and 1968 influenza pandemics

Schedule a free discovery call to see if our supportive, personalized approach is the right fit for you

Within 90 days of surgery, those receiving GLP-1 RAs demonstrated lower hospital readmission rates and reduced incidence of sepsis (Table 2)

Friedrich N, Schwarz S, Thonack J, John U, Wallaschofski H, Vlzke H

Lifestyle Changes for Effective Weight Loss While this medication can be a powerful tool in weight loss management, it is important to note that it should be used in conjunction with lifestyle changes for optimal results

Clinical evidence supports safe indefinite semaglutide use in appropriate patients, with studies tracking continuous therapy for over two years showing consistent safety profiles